ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Clin Pharmacol Biopharm; 2021: 211,

Novelty and Compliance of Oral Fast Dissolving Thin Film A Patient Friendly Dosage Form

Madiha Mushtaque1*, Iyad Naeem Muhmmad1, Sidra Kanwal1, Farah Khalid1,2, Rida Masood1 and Aatka Ali1,3
1Department of Pharmaceutics, Faculty of Pharmacy & Pharmaceutical Science, University of Karachi, Pakistan
2Dow University of Health Sciences, Karachi, Pakistan
3Faculty of Pharmacy, Hamdard University, Madinat al-Hikmah, Hakim Mohammad Said Road, Karachi, Pakistan
*Corresponding Author : Madiha Mushtaque, Department of Pharmaceutics, Faculty of Pharmacy & Pharmaceutical Science, University of Karachi, Pakistan, Tel: +92333-3307067, Email: dr.madihamushtaque@gmail.com

Received Date: Jan 18, 2021 / Accepted Date: Jan 25, 2021 / Published Date: Feb 01, 2021

Abstract

The oral fast-dissolving film is an advanced, patient compliant and novel delivery system. The acceptance of this ingenious dosage form is increasing day by day due to its several comparative advantages of being cost-benefit, rapid dissolving without water aid, as well as greatly compliant to both geriatric and pediatric patients in emergency conditions and specific diseases. Moreover, it is a worthwhile dosage form for the drug experiencing pre-systemic metabolism and lesser bioavailability. This review article covers history, advantages, disadvantages, limitations, ideal properties, classification, formulation consideration, method of manufacturing, quality parameters both in-vitro and in-vivo, advancement in technology, commercial trends and literature review of the previous work for oral fast dissolving films. It can be concluded that it one of the fastest-growing dosage forms holding a lot of potentials especially for commercial use due to its unique characteristics, novel attributes, competitive standing, and cost-adequacy.

Citation: Mushtaque M, Muhmmad IN, Kanwal S, Khalid F, Masood R, et al. (2021) Novelty and Compliance of Oral Fast Dissolving Thin Film – A Patient Friendly Dosage Form. Clin Pharmacol Biopharm 10: 211.

Copyright: © 2021 Mushtaque M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top